[EN] ANALOGS OF VINAXANTHONE AND XANTHOFULVIN, METHODS OF SYNTHESIS, AND METHODS OF TREATMENTS THEREOF<br/>[FR] ANALOGUES DE VINAXANTHONE ET DE XANTHOFULVINE, LEURS PROCÉDÉS DE SYNTHÈSE, ET MÉTHODES THÉRAPEUTIQUES LES UTILISANT
申请人:UNIV TEXAS
公开号:WO2015021226A1
公开(公告)日:2015-02-12
The present invention relates generally to methods of synthesis of vinaxanthone and xanthofulvin, novel analogs, and methods of use thereof.
Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
申请人:Kimura Toru
公开号:US20070015820A1
公开(公告)日:2007-01-18
To provide a semaphorin inhibitor; a peripheral or central nerve regeneration promoter which contains said semaphorin inhibitor as an active ingredient; and a preventive or remedy for a neuropathic disease and a neurodegenerative disease containing said nerve regeneration promoter, or the like.
A low-molecular weight compound, which acts at a concentration of 10 μg/ml or below to inhibit the growth cone collapse activity of semaphorin such as semaphorin 3A, semaphorin 6C or the like and/or the nerve outgrowth inhibitory activity of semaphorin in a collagen gel and which does not substantially affect cell proliferation, is obtained from the culture of strain SPF-3059 belonging to the genus
Penicillium.
The low-molecular weight compound with the semaphorin inhibitory activity thus obtained exhibits the in vivo nerve-regeneration promoting action.
Therapeutic or preventive agents for ischemic neuropathy
申请人:Ikeda Kazuhito
公开号:US20070105948A1
公开(公告)日:2007-05-10
Therapeutic or preventive agents for ischemic nerve injury containing as the active ingredient compounds represented by the general formula [2]:
wherein R
1
and R
4
are each independently hydrogen, carboxy, or alkoxycarbonyl; and R
2
and R
5
are each independently hydrogen, hydroxy group, or acyloxy group.